Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > potential biogen acquisitions
View:
Post by Gbathat on Nov 11, 2020 12:39pm

potential biogen acquisitions

And why is PMN not on this list?

https://www.fool.com/investing/2020/11/11/biogens-shopping-list-3-companies-the-biotech-migh/

At least this article suggests biogen might be shopping for some new paths
Comment by M101 on Nov 11, 2020 1:43pm
Excellent question,  we should all be firing this one at management
Comment by Gbathat on Nov 11, 2020 5:21pm
i recommend we support management.  It is their product, their innovation, their IP.  We are along for the ride. It is fine to ask for updates etc if we are not getting them, but we are getting updates.   However, if all the shareholders come across as whining and angry, it does us no good in the long run.  i'd prefer that management see us as supportive, as I think ...more  
Comment by Alex1726 on Nov 11, 2020 6:36pm
This post has been removed in accordance with Community Policy
Comment by Gbathat on Nov 11, 2020 8:15pm
This post has been removed in accordance with Community Policy
Comment by M101 on Nov 11, 2020 9:09pm
This post has been removed in accordance with Community Policy
Comment by M101 on Nov 11, 2020 9:19pm
This post has been removed in accordance with Community Policy
Comment by Actuarial on Nov 11, 2020 7:28pm
nice joke. you know, few millions collected from shareholders are only enough to issue the management pay cheques every month. you are not going to see clinical trials happen without a partnership. no deal no future for PMN.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse